LUNG CANCER (SCLC)
Clinical trials for LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple combo targets tough lung cancer liver spread
Disease control Not yet recruitingThis study tests whether adding radiotherapy to immunotherapy and chemotherapy can help people with advanced small cell lung cancer that has spread to the liver. It includes 30 adults aged 18-75 who have already tried standard treatments. The goal is to see if the combination shr…
Matched conditions: LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New scan could reveal which tumors respond to immunotherapy
Diagnosis Not yet recruitingThis study tests a special PET scan that uses a radioactive probe to detect PD-L1, a protein on tumor cells. It aims to help doctors identify which patients with lung cancer, melanoma, or other solid tumors are most likely to benefit from immunotherapy. About 40 adults will recei…
Matched conditions: LUNG CANCER (SCLC)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated May 07, 2026 18:40 UTC